Summary:

- The article discusses the issue of substandard and counterfeit drugs manufactured, sold, and marketed in India. It highlights concerns about the quality and safety of these drugs, which can pose serious health risks to consumers.

- The article explains that the Indian pharmaceutical industry is one of the largest in the world, but it also faces challenges in ensuring the quality and integrity of its drug supply. Factors like lack of proper regulation, inadequate infrastructure, and the presence of unscrupulous players contribute to the problem.

- The article emphasizes the need for stronger regulatory oversight, better supply chain management, and more effective enforcement measures to address the issue of substandard and counterfeit drugs in India. It also calls for increased awareness among consumers about the importance of purchasing medicines from reliable sources.